General Manager of the Hellenic Association of Pharmaceutical Companies (SFEE), Mihalis Himonas speaks about his role spearheading Greece’s main pharma association, the contribution of the pharma industry to GDP, market access challenges, and solutions for creating a sustainable healthcare environment.
As the organization representing the united voice of the pharmaceutical industry in Greece, please give us an overview of the Hellenic Association of Pharmaceutical Companies (SFEE)?
"Our priority is to ensure unhindered access of all patients to both innovative and long-established medicines, reducing inequalities in healthcare provision and improving health outcomes."
